Cargando…

Prognostic Value of Serum Biomarkers in Patients with Idiopathic Pulmonary Fibrosis in Relation to Disease Progression

Background: The aim of this present study was to determine serum biomarker levels and their correlation with respiratory function and the clinical course of patients with idiopathic pulmonary fibrosis (IPF). Materials and Methods: This study included 72 IPF patients, according to the ATS/ERS criteri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Domvri, Kalliopi, Organtzis, Ioannis, Apostolopoulos, Apostolos, Fouka, Evangelia, Kontakiotis, Theodoros, Papakosta, Despoina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532947/ https://www.ncbi.nlm.nih.gov/pubmed/37763075 http://dx.doi.org/10.3390/jpm13091307

Ejemplares similares

Clinical, imaging and functional determinants of sarcoidosis phenotypes in a Greek population
por: Spyropoulos, Georgios, et al.
Publicado: (2022)

Eosinophilic Asthma, Phenotypes-Endotypes and Current Biomarkers of Choice
por: Porpodis, Konstantinos, et al.
Publicado: (2022)

Epidemiology of lung cancer in Northern Greece: An 18-year hospital-based cohort study focused on the differences between smokers and non-smokers
por: Domvri, Kalliopi, et al.
Publicado: (2020)

Recent insights in the role of biomarkers in severe asthma management
por: Fouka, Evangelia, et al.
Publicado: (2022)

Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis
por: Karampitsakos, Theodoros, et al.
Publicado: (2021)

BALF and BLOOD NK- cells in different stages of pulmonary sarcoidosis
por: Manika, Katerina, et al.
Publicado: (2021)

Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study
por: Antoniou, Katerina, et al.
Publicado: (2020)

Cytokine gene polymorphisms in Greek patients with severe asthma
por: Papakosta, Despina, et al.
Publicado: (2015)

Tumour necrosis factor, interferon-gamma and interleukins as predictive markers of antiprogrammed cell-death protein-1 treatment in advanced non-small cell lung cancer: a pragmatic approach in clinical practice
por: Boutsikou, Efimia, et al.
Publicado: (2018)

Prognostic Value of Serum Osteopontin in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Gui, Xianhua, et al.
Publicado: (2020)

Predictive Value of 99MTC-hynic-toc Scintigraphy in Lung Neuroendocrine Tumor Diagnosis
por: Boutsikou, Efimia, et al.
Publicado: (2019)

Electronic Cigarettes and Asthma: What Do We Know So Far?
por: Kotoulas, Serafeim-Chrysovalantis, et al.
Publicado: (2021)

Health costs from hospitalization with H1N1 infection during the 2009–2010 influenza pandemic compared with non-H1N1 respiratory infections
por: Zarogoulidis, Paul, et al.
Publicado: (2012)

Omalizumab: An Optimal Choice for Patients with Severe Allergic Asthma
por: Kotoulas, Serafeim Chrysovalantis, et al.
Publicado: (2022)

Assessing the Burden and Prognostic Value of Cough in Idiopathic Pulmonary Fibrosis
por: Johnston, Janet, et al.
Publicado: (2023)

Serum AGE/RAGEs as potential biomarker in idiopathic pulmonary fibrosis
por: Machahua, Carlos, et al.
Publicado: (2018)

A case of typical pulmonary carcinoid tumor treated with bronchoscopic therapy followed by lobectomy
por: Porpodis, Konstantinos, et al.
Publicado: (2012)

Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis
por: Kreuter, Michael, et al.
Publicado: (2021)

Molecular and Genetic Biomarkers in Idiopathic Pulmonary Fibrosis: Where Are We Now?
por: Tomos, Ioannis, et al.
Publicado: (2023)

Pulmonary thromboendarterectomy after treatment with treprostenil in a chronic thromboembolic pulmonary hypertension patient: a case report
por: Porpodis, Konstantinos, et al.
Publicado: (2011)

Blood Biomarkers in Idiopathic Pulmonary Fibrosis
por: Guiot, Julien, et al.
Publicado: (2017)

The Prognostic Value of Integrated Analysis of Inflammation and Hypoxia-Related Genes in Idiopathic Pulmonary Fibrosis
por: Liu, Jun, et al.
Publicado: (2022)

IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosis
por: Nakanishi, Yu, et al.
Publicado: (2021)

Roflumilast, a phosphodiesterase-4 inhibitor, induces phagocytic activity in Greek COPD patients
por: Porpodis, Konstantinos, et al.
Publicado: (2015)

Hydrocarbon pneumonitis following liquid paraffin aspiration during a fire-eating performance: a case report
por: Mylonaki, Efrosyni, et al.
Publicado: (2008)

Macrophage-Derived Biomarkers of Idiopathic Pulmonary Fibrosis
por: Bargagli, E., et al.
Publicado: (2011)

Biomarkers of cellular senescence in idiopathic pulmonary fibrosis
por: Aversa, Zaira, et al.
Publicado: (2023)

Williams–Campbell syndrome: a case report
por: Konoglou, Maria, et al.
Publicado: (2012)

Ferroptosis-Related Genes in Bronchoalveolar Lavage Fluid Serves as Prognostic Biomarkers for Idiopathic Pulmonary Fibrosis
por: Li, Meng, et al.
Publicado: (2021)

The Aggregate Index of Systemic Inflammation (AISI): A Novel Prognostic Biomarker in Idiopathic Pulmonary Fibrosis
por: Zinellu, Angelo, et al.
Publicado: (2021)

Blood monocyte counts as a prognostic biomarker and predictor in Chinese patients with idiopathic pulmonary fibrosis
por: Zhang, Xinran, et al.
Publicado: (2022)

Prognostic analysis of m6A-related genes as potential biomarkers in idiopathic pulmonary fibrosis
por: Wang, Zhiqiang, et al.
Publicado: (2022)

Oxidative and pre-inflammatory stress in wedge resection of pulmonary parenchyma using the radiofrequency ablation technique in a swine model
por: Karaiskos, Theodoros, et al.
Publicado: (2012)

Combined pulmonary fibrosis and emphysema characteristics in a Greek cohort
por: Malli, Foteini, et al.
Publicado: (2019)

Prognostic impact of malignant diseases in idiopathic pulmonary fibrosis
por: Lee, Hong Yeul, et al.
Publicado: (2020)

Tissue is an issue in the search for biomarkers in idiopathic pulmonary fibrosis
por: Kaarteenaho, Riitta, et al.
Publicado: (2015)

Importance of serial changes in biomarkers in idiopathic pulmonary fibrosis
por: Sokai, Akihiko, et al.
Publicado: (2017)

Sputum exosomes: promising biomarkers for idiopathic pulmonary fibrosis
por: Njock, Makon-Sébastien, et al.
Publicado: (2019)

Enhancement of Aerosol Cisplatin Chemotherapy with Gene Therapy Expressing ABC10 protein in Respiratory System
por: Hohenforst-Schmidt, Wolfgang, et al.
Publicado: (2014)

Precision medicine advances in idiopathic pulmonary fibrosis
por: Karampitsakos, Theodoros, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_42m8k63360cvf3ena3jupa7qig